Varinder Singh – författare

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Treatments and potential cures for Alzheimer’s have been researched for a long time now. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set, Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer’s Disease, 2-volume set, represents a collective effort to delve into the potential of nature’s pharmacopeia in our battle against Alzheimer’s disease. The editors posit that essential insights into the intricacies of the disease are the foundation for subsequent discussions on potential therapeutic interventions.

Volume 1: Targeting Key Pathological Pathways first lays the foundation by unveiling the underlying pathological, biochemical, molecular, and genetic aspects of Alzheimer’s disease. These chapters provide essential insights into the intricacies of the disease and serve as a springboard for the subsequent discussions on potential therapeutic interventions. Chapters cover pathophysiology and diagnosis, the connection of gut microbiome and Alzheimer’s disease, drug-induced Alzheimer’s disease, and more. The volume then goes on to shine a spotlight on the vast potential of nutraceuticals in managing Alzheimer’s disease. It explores a plethora of medicinal plants and their secondary metabolites that show promise in treating this devastating condition. From preclinical findings to clinical studies, the chapters present a wealth of knowledge on memory improvement effects and the mechanisms underlying the actions of these neuronutraceuticals. Covered are the role of diet, micronutrients, and macronutrients in managing Alzheimer’s disease; Medhya Rasayana (medicinal plants described in the Indian system of medicine that are said to improve memory and intellect); nootropics (also known as drug cognitive enhancers that help to improve memory, increase mental alertness and concentration as well as boost energy levels and wakefulness); and other ethnopharmacological approaches for dementia.

Together, these volumes not only reflect the current state of knowledge but also pave the way for future exploration in the field. Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer’s Disease will enlighten readers, whether seasoned researchers, practitioners, or advanced students, with a wealth of scientific knowledge gained through the cutting-edge research and in-depth exploration of the therapeutic potential of nature’s offerings and shall contribute to the ongoing efforts in managing dementia and cognitive disorders.

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Treatments and potential cures for Alzheimer’s have been researched for a long time now. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set, Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer’s Disease, 2-volume set, represents a collective effort to delve into the potential of nature’s pharmacopeia in our battle against Alzheimer’s disease. The editors posit that essential insights into the intricacies of the disease are the foundation for subsequent discussions on potential therapeutic interventions.

Volume 1: Targeting Key Pathological Pathways first lays the foundation by unveiling the underlying pathological, biochemical, molecular, and genetic aspects of Alzheimer’s disease. These chapters provide essential insights into the intricacies of the disease and serve as a springboard for the subsequent discussions on potential therapeutic interventions. Chapters cover pathophysiology and diagnosis, the connection of gut microbiome and Alzheimer’s disease, drug-induced Alzheimer’s disease, and more. The volume then goes on to shine a spotlight on the vast potential of nutraceuticals in managing Alzheimer’s disease. It explores a plethora of medicinal plants and their secondary metabolites that show promise in treating this devastating condition. From preclinical findings to clinical studies, the chapters present a wealth of knowledge on memory improvement effects and the mechanisms underlying the actions of these neuronutraceuticals. Covered are the role of diet, micronutrients, and macronutrients in managing Alzheimer’s disease; Medhya Rasayana (medicinal plants described in the Indian system of medicine that are said to improve memory and intellect); nootropics (also known as drug cognitive enhancers that help to improve memory, increase mental alertness and concentration as well as boost energy levels and wakefulness); and other ethnopharmacological approaches for dementia.

Together, these volumes not only reflect the current state of knowledge but also pave the way for future exploration in the field. Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer’s Disease will enlighten readers, whether seasoned researchers, practitioners, or advanced students, with a wealth of scientific knowledge gained through the cutting-edge research and in-depth exploration of the therapeutic potential of nature’s offerings and shall contribute to the ongoing efforts in managing dementia and cognitive disorders.

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of nature’s pharmacopeia in our battle against Alzheimer’s disease.

Volume 2: Strategies to Unlock the Brain’s Fortress offers a comprehensive exploration into the cutting-edge strategies for the pursuit of effective Alzheimer’s management. It first offers a holistic exploration of nutraceuticals and their pivotal role in managing Alzheimer’s disease, serving as a guide to the diverse array of neuro-nutraceuticals and providing insights into their mechanisms, efficacy, and potential integration into holistic Alzheimer’s management strategies. The book looks at natural antioxidant therapeutics, natural steroidal phytopharmaceuticals and Terpenes (aromatic compounds found in many plants), anti-apoptotic natural products, polysaccharides, neuro-protective role of vitamin D, and non-flavonoidal agents for the effective treatment of Alzheimer’s. Recent developments and advancements in the delivery of nutraceuticals are explored as well, looking at nanotechnology and advanced drug delivery systems for therapeutic interventions.

Volume 1: Targeting Key Pathological Pathways covers the pathophysiology and diagnosis of Alzheimer’s disease, its connection to gut microbiome, drug-induced Alzheimer’s disease, and more, also discussing the vast potential of nutraceuticals in managing Alzheimer’s disease. It explores a plethora of medicinal plants and their secondary metabolites that show promise in treating this devastating condition.

Together, these volumes not only reflect the current state of knowledge but also pave the way for future exploration in the field.

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of nature’s pharmacopeia in our battle against Alzheimer’s disease.

Volume 2: Strategies to Unlock the Brain’s Fortress offers a comprehensive exploration into the cutting-edge strategies for the pursuit of effective Alzheimer’s management. It first offers a holistic exploration of nutraceuticals and their pivotal role in managing Alzheimer’s disease, serving as a guide to the diverse array of neuro-nutraceuticals and providing insights into their mechanisms, efficacy, and potential integration into holistic Alzheimer’s management strategies. The book looks at natural antioxidant therapeutics, natural steroidal phytopharmaceuticals and Terpenes (aromatic compounds found in many plants), anti-apoptotic natural products, polysaccharides, neuro-protective role of vitamin D, and non-flavonoidal agents for the effective treatment of Alzheimer’s. Recent developments and advancements in the delivery of nutraceuticals are explored as well, looking at nanotechnology and advanced drug delivery systems for therapeutic interventions.

Volume 1: Targeting Key Pathological Pathways covers the pathophysiology and diagnosis of Alzheimer’s disease, its connection to gut microbiome, drug-induced Alzheimer’s disease, and more, also discussing the vast potential of nutraceuticals in managing Alzheimer’s disease. It explores a plethora of medicinal plants and their secondary metabolites that show promise in treating this devastating condition.

Together, these volumes not only reflect the current state of knowledge but also pave the way for future exploration in the field.